Groarke 2018.
Trial name or title | |
Methods |
Design: pilot randomised controlled trial retrospective Country: Ireland Accrual dates: NR Trial Reg: ISRCTN18676721 |
Participants | Overweight/obese cancer survivors |
Interventions | The study is employing a 2 groups (experimental and control) x 3 time points (baseline, 3 months, 6 months) mixed analysis of variance design to investigate the impact of a personalised solution (wear a Fitbit activity monitor, using a personalised dietary or physical activity intervention that will employ an educational component along with a shared decision‐making and goal‐setting model) vs standard care on primary and secondary health outcomes |
Outcomes | Primary outcomes: Average daily step count, measured via Fitbit device continuously for 6 months BMI and weight Secondary outcomes: Sleep quality, measured via Fitbit device continuously for 6 months The following measures are recorded Physical fitness, measured using 6‐minute walk test ‐ resting HR, BP, SpO2, recovery HR, BP, SpO2 Dietary behaviour, measured using Food Frequency Questionnaire General health status (MOS SF‐36; Ware et al, 2000), fatigue (Mendoza, Wang, Cleeland, et al., 1999), self‐efficacy (Schwarzer & Jerusalem, 2010), exercise self‐efficacy (Bandura, 2006), exercise‐related social support (Sallis et al, 1987) |
Starting date | August 2017 |
Contact information | Dr. Jenny Groarke, National University of Ireland, Galway |
Notes | Protocol |